Monthly Archives: June 2017

Corporate News Blog – Government Properties Income Trust to Acquire First Potomac Realty Trust; Set to Expand its Property Portfolio in Metropolitan Washington, D.C. Area

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for First Potomac Realty Trust (NYSE: FPO) (“FPO”), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=FPO. Government Properties Income Trust (NASDAQ: GOV) (“GOV”) announced on June 28, 2017, that its Board of Directors has unanimously approved a definitive merger agreement, pursuant to which it will acquire all the outstanding common shares of First Potomac Realty Trust for about $1.4 billion, including $11.15 per FPO’s common share in cash and repayment or assumption of FPO’s debt. The transaction is subject to the approval of at least a majority of FPO’s common shareholders and other customary closing conditions and is expected to close prior to the end of 2017. For immediate access to our complimentary reports, including today’s coverage, register for free now at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on FPO and GOV. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=FPO

http://protraderdaily.com/optin/?symbol=GOV

The Announcement

GOV views this announcement as a step to expand its business strategy to include the acquisition, ownership, and operation of office properties leased to both government and private sector tenants in the metropolitan Washington, D.C. market area. Currently, the Metropolitan Washington D.C. market area is one of the largest office markets in the US and is the nation’s largest beneficiary of spending by the Government of United States. Outside of the particular area, GOV will incline its focus on acquiring, owning, and operating office properties that are majority leased to government tenants.

GOV believes that the high-quality office and industrial properties from FPO are well located in the metropolitan market area, and are complementary to the Company’s portfolio. Currently, FPO’s portfolio includes 39 properties, or 74 buildings comprising of about 6.5 million square feet, that was 92.2% leased as of March 31, 2017. As of March 31, 2017, government and other investment grade rated tenants represented about 43.9% of FPO’s net annualized rental income.

The Company expects this transaction to deliver multiple potential growth opportunities while realizing about $11 million of annual general and administrative expense savings, compared against FPO on a stand-alone basis.

Operating Metrics

As of March 31, 2017, before the acquisition of FPO, the Company’s portfolio included $4.1 billion of consolidated gross assets with 113 properties spanning over 18 million square feet which are 94.1% leased for 4.9 years on weighted average annualized rental income.

GOV generated 71.7% of the total annualized rental income from government and other investment grade tenants, of which 59.9% of the total annualized rental income was generated from government tenants. Currently, GOV’s properties are located in 31 states and Washington, D.C., where the Company generates 54.3% of total annualized rental income from the metropolitan Washington, D.C. market area.

Financing Details

The net payable amount of $1.4 billion includes the cash consideration to be paid to FPO’s shareholders of about $683 million in aggregate, and about $418 million of FPO’s debt and about $232 million of FPO’s mortgage debt, and the payment of transaction fees and expenses, net of FPO’s cash on hand.

GOV plans to finance this transaction on a long-term basis with the sale of common shares, additional debt, including senior unsecured notes, mortgage financing and/or bank debt, and/or with proceeds from the sale of certain properties. The Company believes that the transaction is accretive to GOV’s normalized funds from operations per share after 2018 and approximately leveraging neutral on a debt to gross assets basis after completion of GOV’s long-term financing plan.

Last Close Stock Review

First Potomac Realty Trust’s share price finished yesterday’s trading session at $11.11, rising slightly by 0.45%. A total volume of 1.77 million shares have exchanged hands, which was higher than the 3-month average volume of 352.08 thousand shares. The Company’s stock price rallied 9.03% in the last three months, 5.21% in the past six months, and 21.29% in the previous twelve months. Additionally, the stock gained 1.28% since the start of the year. Shares of the Company have a PE ratio of 17.22 and have a dividend yield of 3.60%. The stock currently has a market cap of $643.05 million.

At the closing bell, on Thursday, June 29, 2017, Government Properties Income Trust’s stock tumbled 5.28%, ending the trading session at $18.31. A total volume of 20.48 million shares have exchanged hands, which was higher than the 3-month average volume of 591.35 thousand shares. The stock is trading at a PE ratio of 26.77 and has a dividend yield of 9.39%. The stock currently has a market cap of $1.30 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467188

Corporate News Blog – Fluor Corp. Signs MoU with Saudi Arabian Mining Firm, Ma’aden

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Fluor Corp. (NYSE: FLR), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=FLR. The Company announced on June 28, 2017, that it has signed a Memorandum of Understanding (MOU) with Saudi Arabian Mining Company, Ma’aden, to support future Ma’aden projects located within and outside the Kingdom of Saudi Arabia. Fluor has already worked with Ma’aden for over 10 years, where the Company executed work in excess of $15 billion for projects, including the Ma’aden Aluminum Complex and the ongoing Umm Wu’al Phosphate Project. For immediate access to our complimentary reports, including today’s coverage, register for free now at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on FLR. Go directly to your stock of interest and access today’s free coverage at: http://protraderdaily.com/optin/?symbol=FLR.

The Announcement

Under terms of the MoU, Fluor will be considered for conceptual, pre front-end engineering and design (FEED), engineering, procurement, and construction management, and program management contracting for future projects. This understanding would enable both the Companies to increase their involvement in Saudi Arabia and expand their services and offerings, outside the Kingdom. Fluor has been operating in Saudi Arabia since 1947, and under the partnership with Ma’aden, the Company has delivered several of their mega-projects.

The Umm Wu’al Phosphate Project

Ma’aden and J.V. partners, under collaboration, are building a new phosphate plant in Wa’ad Al Shamal Industrial City, where other mineral and secondary production industries will be added at a later date. Once completed the facility will have an annual capacity of 3 million MTPA of DAP/MAK and NPK fertilizers, and will be one of the largest integrated phosphate fertilizer facilities in the world.

Fluor has hired more than 80 Saudi national to support the project, who were delivered detailed training on Fluor’s processes and procedures. The Company set a goal of at least 20% Saudi local content, with a peak site workforce of 28,000 spanning more than 50 nationalists. Fluor additionally implemented its world-class safety programs, including Fluor’s Life CriticalSM program, to support the project. As a result of these programs, the project, across all contractors, has achieved more than 31 million work hours without a lost-time incident as of January 2017.

Other Contracts

Fluor, along with CH2M and BWX Technologies, formed a joint venture, namely, Four Rivers Nuclear Partnership, LLC, which was awarded the Paducah Deactivation and Remediation contract on May 30, 2017. The performance-based contract is valued at about $1.5 billion over 10 years. Also, the base term is 5 years, valued at about $750 million, followed by 3-year and 2-year options periods valued at a total of about $750 million combined.

The Company was additionally awarded the WoodFibre LNG Project in Canada, where it signed a definitive agreement on February 16, 2017, with JGC America, Inc., to deliver construction-related support to the front-end engineering and design services for the Woodfibre Liquefied Natural Gas project in the District of Squamish near Vancouver, British Columbia, Canada. The proposed facility will be powered by electricity from BC Hydro, which currently generates more than 90% clean renewable energy and helps create one of the cleanest LNG facilities in the world. Fluor booked the undisclosed contract value in Q4 FY16.

Last Close Stock Review

On Thursday, June 29, 2017, the stock closed the trading session at $45.07, marginally down 0.66% from its previous closing price of $45.37. A total volume of 830.97 thousand shares have exchanged hands. Fluor’s stock price advanced 0.47% in the last one month. The stock is trading at a PE ratio of 26.72 and has a dividend yield of 1.86%. The stock currently has a market cap of $6.28 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467194

Featured Company News – Philips to Acquire Spectranetics; Set to Expand its Image-Guided Therapy Portfolio

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Koninklijke Philips N.V. (NYSE: PHG), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=PHG.

The Company announced on June 28, 2017, that under a definitive merger agreement, it has acquired Spectranetics Corp. (NASDAQ: SPNC), a US-based global leader in vascular intervention and lead management solutions. The implied transaction is valued at about €1.5 billion and includes Spectranetics’ cash and debt. For immediate access to our complimentary reports, including today’s coverage, register for free now at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on PHG and SPNC. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=PHG

http://protraderdaily.com/optin/?symbol=SPNC

The Announcement

Philips, a global leader in health technology, has a market-leading position in the €6 billion image-guided therapy market with a unique portfolio of interventional imaging systems and devices, planning and navigation software and services, where it serves a large customer base and is supported by a global network of leading clinical partners.

Philips views this acquisition as a step to further expand and strengthen its position in the Image-Guided Therapy Business Group. Spectranetics, being a leader in vascular intervention to treat coronary and peripheral artery disease, is complementary to Philips’ portfolio. Also, Spectranetics is a leading provider of minimally invasive removal of implanted pacemaker and implantable cardioverter defibrillator leads. The Company currently is growing double digits and projects FY17 sales in the range of $293 million to $306 million.

Spectranetics Portfolio

Spectranetics’ device portfolio includes a range of laser atherectomy catheters for treatment of blockages with lasers in both coronary and peripheral arteries. The portfolio additionally includes AngioSculpt scoring balloon, used to mechanically push a blockage aside in both peripheral and coronary arteries and the AngioSculptX scoring balloon, which according to the Company is the only drug-coated scoring balloon presently, and the Stellarex drug-coated balloon which is used to treat common to complex lesions while inhibiting the recurrence of these blockages. The Stellarex drug-coated balloon is the key growth driver for the Company where it is already CE market and under review by the FDA for premarket approval in the United States.

Financial Details

Philips will commence a tender offer to acquire all of the outstanding shares of Spectranetics for $38.50 per share, to be paid in cash upon completion. This price represents a 27% premium to the Spectranetics’ closing price on June 27, 2017. Spectranetics’ Board of Directors have approved the transaction and recommended the offer to its shareholders, while the transaction is expected to close in Q3 FY17.

Upon completion of the transaction, Spectranetics and its workforce of over 900 employees will become part of the Image-Guided Business Group within Philips. The Company views sustained high sales growth through new product introductions across a decidedly synergistic therapy device portfolio.

Company Growth Prospects

This transaction is viewed by Spectranetics as a step to enhance the geographical reach of its products and harness mass commercialization opportunities in new, adjacent segments. As a part of the Company, Spectranetics will benefit immediately from Philips platform enabling cost and working capital synergies. As a result of the transaction, the combined Spectranetics and Philips Image Guided Therapy Devices business are expected to grow to about €1 billion by 2020.

Philips, in an attempt to establish itself as the leader in the healthcare segment, announced on June 01, 2017, a research agreement with Memorial Sloan Kettering Cancer Center to jointly develop advanced genome analytics for precision oncology. Philips and Memorial Sloan Kettering already have research collaboration in the field of radiation oncology, where MR imaging is used for treatment planning.

Last Close Stock Review

At the closing bell, on Thursday, June 29, 2017, Koninklijke Philips’ stock slipped 1.90%, ending the trading session at $35.72. A total volume of 1.00 million shares have exchanged hands. The Company’s stock price skyrocketed 11.42% in the last three months, 18.40% in the past six months, and 46.39% in the previous twelve months. Moreover, the stock surged 16.85% since the start of the year. The stock is trading at a PE ratio of 25.10 and has a dividend yield of 2.41%. The stock currently has a market cap of $34.03 billion.

Spectranetics’ share price finished yesterday’s trading session flat at $38.35. A total volume of 6.00 million shares have exchanged hands, which was higher than the 3-month average volume of 895.21 thousand shares. The Company’s stock price skyrocketed 35.04% in the last three months, 56.21% in the past six months, and 109.33% in the previous twelve months. Additionally, the stock soared 56.53% since the start of the year. At Thursday’s closing price, the stock’s net capitalization stands at $1.66 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467190

Canadian Healthcare Stocks Under Review: Valeant Pharma International, Knight Therapeutics, Merus Labs International, and Nuvo Pharma

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Drug Manufacturers industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Valeant Pharmaceuticals International, Knight Therapeutics, Merus Labs International, and Nuvo Pharmaceuticals. Register for these free reports at: http://protraderdaily.com/register/.

On Thursday, June 29, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,213.42, 0.93% lower, with a total volume of 342,617,533 shares.

Additionally, the Healthcare index was slightly down by 0.96%, ending the session at 71.00.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: Valeant Pharmaceuticals International Inc. (TSX: VRX), Knight Therapeutics Inc. (TSX: GUD), Merus Labs International Inc. (TSX: MSL), and Nuvo Pharmaceuticals Inc. (TSX: NRI). Sign up now for your free membership and research reports at: http://protraderdaily.com/register/.

Valeant Pharmaceuticals International Inc. (TSX: VRX)

Laval, Canada headquartered Valeant Pharmaceuticals International Inc.’s stock edged 0.22% higher, to finish Thursday’s session at $22.46 with a total volume of 3.72 million shares traded. Over the last one month and the previous three months, Valeant Pharma’s shares have surged 36.29% and 52.27%, respectively. Shares of the Company, which operates as a pharmaceutical and medical device company worldwide, are trading above its 50-day and 200-day moving averages. Valeant Pharma’s 50-day moving average of $18.03 is above its 200-day moving average of $17.27. See our research report on VRX.TO at: http://protraderdaily.com/optin/?symbol=VRX.

Knight Therapeutics Inc. (TSX: GUD)

On Thursday, shares in Montreal, Canada headquartered Knight Therapeutics Inc. recorded a trading volume of 420,094 shares, which was higher than their three months average volume of 120,382 shares. The stock ended the day 0.58% lower at $10.29. Knight Therapeutics’ stock has gained 3.31% in the last one month and 24.43% in the previous one year. The Company’s shares are trading above its 50-day and 200-day moving averages. The stock’s 200-day moving average of $10.28 is above its 50-day moving average of $10.01. Shares of the Company, which engages in developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada and internationally, are trading at a PE ratio of 57.81. The complimentary research report on GUD.TO at: http://protraderdaily.com/optin/?symbol=GUD.

Merus Labs International Inc. (TSX: MSL)

On Thursday, shares in Toronto, Canada headquartered Merus Labs International Inc. ended the session flat at $1.63 with a total volume of 1.21 million shares traded. Merus Labs’ shares have gained 1.87% in the last one month and 32.52% in the previous three months. Shares of the Company, which owns, markets, and distributes pharmaceutical products primarily in Europe and Canada, are trading above its 50-day and 200-day moving averages. Furthermore, the stock’s 50-day moving average of $1.60 is greater than its 200-day moving average of $1.25. Register for free and access the latest research report on MSL.TO at: http://protraderdaily.com/optin/?symbol=MSL.

Nuvo Pharmaceuticals Inc. (TSX: NRI)

Mississauga, Canada headquartered Nuvo Pharmaceuticals Inc.’s stock closed the day 1.17% higher at $4.32. The stock recorded a trading volume of 100 shares, below its three months average volume of 29,706 shares. The Company’s shares are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $5.22 is greater than its 50-day moving average of $4.43. Shares of Nuvo Pharma, which produces and sells pharmaceutical products in the US, Canada, and Europe, are trading at a PE ratio of 6.48. Get free access to your research report on NRI.TO at: http://protraderdaily.com/optin/?symbol=NRI.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467209

Daily Coverage on Basic Materials Stocks: Sherritt International, Northern Dynasty Minerals, Detour Gold, and Silvercorp Metals

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Metals & Mining industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Sherritt International, Northern Dynasty Minerals, Detour Gold, and Silvercorp Metals. Register for these free reports at: http://protraderdaily.com/register/.

At the closing bell on Thursday, June 29, 2017, the Toronto Exchange Composite index edged 0.93% lower to finish the trading session at 15,213.42 with a total volume of 342,617,533 shares exchanging hands for the day.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: Sherritt International Corporation (TSX: S), Northern Dynasty Minerals Ltd (TSX: NDM), Detour Gold Corporation (TSX: DGC), and Silvercorp Metals Inc. (TSX: SVM). Sign up now for your free membership and research reports at: http://protraderdaily.com/register/.

Sherritt International Corp. (TSX: S)

Toronto, Canada-based Sherritt International Corp.’s stock lost 1.30%, to finish Thursday’s session at $0.76 with a total volume of 671,685 shares traded. Shares of the Company, which engages in mining and refining nickel from lateritic ores in Canada, Cuba, and Madagascar, are trading below its 50-day and 200-day moving averages. Sherritt International’s 200-day moving average of $1.08 is above its 50-day moving average of $0.80. See our research report on S.TO at: http://protraderdaily.com/optin/?symbol=S.

Northern Dynasty Minerals Ltd. (TSX: NDM)

On Thursday, shares in Vancouver, Canada headquartered Northern Dynasty Minerals Ltd recorded a trading volume of 589,170 shares. The stock ended the day 5.29% lower at $1.79. Northern Dynasty Minerals’ stock has rallied 358.97% in the previous one year. Shares of the Company, which acquires, explores for, and develops mineral properties in the US, are trading below its 50-day and 200-day moving averages. The stock’s 200-day moving average of $2.44 is above its 50-day moving average of $2.23. The complimentary research report on NDM.TO at: http://protraderdaily.com/optin/?symbol=NDM.

Detour Gold Corp. (TSX: DGC)

On Thursday, shares in Toronto, Canada headquartered Detour Gold Corp. ended the session 2.17% lower at $14.85 with a total volume of 1.03 million shares traded. Shares of the Company, which engages in the acquisition, exploration, development, and operation of mineral properties in Canada, are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 50-day moving average of $17.10 is greater than its 200-day moving average of $17.05. Register for free and access the latest research report on DGC.TO at: http://protraderdaily.com/optin/?symbol=DGC.

Silvercorp Metals Inc. (TSX: SVM)

Vancouver, Canada headquartered Silvercorp Metals Inc.’s stock closed the day 0.93% lower at $4.25. The stock recorded a trading volume of 610,036 shares. Silvercorp Metals’ shares have gained 10.66% in the last one month and 22.46% in the past one year. Shares of the Company, which together with its subsidiaries, engages in the acquisition, exploration, development, and mining of precious and base metal mineral properties in China, are trading above their 50-day moving average. Moreover, the stock’s 200-day moving average of $4.25 is greater than its 50-day moving average of $4.05. Get free access to your research report on SVM.TO at: http://protraderdaily.com/optin/?symbol=SVM.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467208

Report Coverage on Technology Stocks: Edgewater Wireless Systems, Wi2Wi, Sierra Wireless, and Evertz Technologies

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Communication Equipment industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Edgewater Wireless Systems, Wi2Wi, Sierra Wireless, and Evertz Technologies. Register for these free reports at: http://protraderdaily.com/register/.

On Thursday, June 29, 2017, the TSX Venture Composite Index was down 0.92%, finishing the day at 762.40. The Toronto Exchange Composite Index, on the other hand, closed at 15,213.42, down 0.93%.

The Technology Index was also in the red, closing the day at 61.63, down 1.68%.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: Edgewater Wireless Systems Inc. (TSX-V: YFI), Wi2Wi Corporation (TSX-V: YTY), Sierra Wireless Inc. (TSX: SW), and Evertz Technologies Ltd. (TSX: ET). Sign up now for your free membership and research reports at: http://protraderdaily.com/register/.

Edgewater Wireless Systems Inc. (TSX-V: YFI)

Ottawa, Canada headquartered Edgewater Wireless Systems Inc.’s stock advanced 1.85%, to finish Thursday’s session at $0.28 with a total volume of 153,370 shares traded. Edgewater Wireless Systems’ shares have gained 30.95% in the past one year. Shares of the Company, which develops and commercializes technologies and intellectual property for the wireless communications market in Europe, Asia, North America, and Central America, are trading above its 50-day moving average. Edgewater Wireless Systems’ 200-day moving average of $0.29 is above its 50-day moving average of $0.27. See our research report on YFI.V at: http://protraderdaily.com/optin/?symbol=YFI.

Wi2Wi Corp. (TSXV: YTY)

On Thursday, shares in San Jose, California headquartered Wi2Wi Corp. recorded a trading volume of 24,500 shares. The stock ended the day 4.17% lower at $0.12. Wi2Wi’s stock has rallied 91.67% in the previous one year. The Company’s shares are trading above its 200-day moving average. The stock’s 50-day moving average of $0.12 is above its 200-day moving average of $0.09. Shares of the Company, which provides wireless technology solutions worldwide, are trading at a PE ratio of 57.50. The complimentary research report on YTY.V at: http://protraderdaily.com/optin/?symbol=YTY.

Sierra Wireless Inc. (TSX: SW)

On Thursday, shares in Richmond, Canada headquartered Sierra Wireless Inc. ended the session 2.31% lower at $36.79 with a total volume of 97,433 shares traded. Sierra Wireless’ shares have gained 4.84% in the last three months and 65.65% in the previous one year. The stock is trading above its 200-day moving average. Furthermore, the stock’s 50-day moving average of $38.07 is greater than its 200-day moving average of $32.41. Shares of Sierra Wireless, which together with its subsidiaries, engages in building the Internet of Things with intelligent wireless solutions in North America, Europe, and Asia/Pacific, are trading at a PE ratio of 81.39. Register for free and access the latest research report on SW.TO at: http://protraderdaily.com/optin/?symbol=SW.

Evertz Technologies Ltd (TSX: ET)

Burlington, Canada headquartered Evertz Technologies Ltd’s stock closed the day 0.56% higher at $17.80. The stock recorded a trading volume of 30,388 shares, which was above its three months average volume of 19,371 shares. Evertz Technologies’ shares have gained 6.45% in the last one month and 12.09% in the past three months. Shares of the Company, which designs, manufactures, and distributes video and audio infrastructure solutions for the production, post-production, and transmission of television content in Canada, the US, and internationally, are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $17.15 is greater than its 200-day moving average of $16.84. Get free access to your research report on ET.TO at: http://protraderdaily.com/optin/?symbol=ET.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467206

Featured Company News – Santhera Selected Veeva CRM and Veeva OpenData as Commercial Software and Data Platform

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Veeva Systems Inc. (NYSE: VEEV), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=VEEV. The Company announced on June 28, 2017, that Santhera Pharmaceuticals, a rare disease pharmaceutical Company, has selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The Company will adopt Veeva Commercial Cloud Solutions to establish a consistent, global approach to commercialization. For immediate access to our complimentary reports, including today’s coverage, register for free now at: http://protraderdaily.com/register/.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on VEEV. Go directly to your stock of interest and access today’s free coverage at: http://protraderdaily.com/optin/?symbol=VEEV.

The Announcement

According to the Company, accurate customer data is the foundation for commercial excellence, and especially, with the growing number of stakeholders, robust and accurate data update turns to be of utmost importance. Veeva currently offers complete customer data and multichannel engagement to help life sciences organizations and pharmaceutical Companies enhance their interactions with healthcare professionals across the world.

The Company offers field team access to up-to-date customer reference data, where they need it most to enable faster and tailored interactions. When a particular user submits data change requests, it is properly verified and updated within hours, against the industry average of 10 or more days. Veeva recently announced that 100 customers have adopted Veeva OpenData, including Allergan, which like other firms, has moved to Veeva OpenData for more up-to-date and complete customer reference data.

Veeva stated that according to a recent survey, a majority of Companies struggle with customer data quality issues, where incorrect physician addresses, lack of information about the right doctor to contact, or outdated information about specialty and license status, creates a sense of frustration among the field employees, hence affecting the operational performance of the individuals. Accordingly, the Company stated that on the basis of its research, about 78% of the Companies have initiatives underway to enhance data quality within the next two years.

Veeva CRM Events Management

Last year, on December 12, 2016, the Company announced that Advanced Health Media (AHM), HealthSTAR Communications, MedForce, Physicians World, and Vector Health are leveraging the power of Veeva CRM Events Management to offer life sciences customers a full-fledged end-to-end solution for enterprise-wide planning and execution of live and virtual events. According to the Company, about 75% of organizations report that the use of disparate systems is the biggest issue in events management. Hence, in an attempt to minimize the burden, leading Companies are integrating and certifying their offerings with Veeva CRM Events Management, a single solution to plan and execute all events across the enterprise.

The Company

Veeva Systems is a leading cloud-based software provider for the global life sciences segment. The Company currently has about 525 customers under its portfolio, with offices in Europe, Asia, Latin America, and headquarters at San Francisco’s Bay Area. The Company’s Veeva OpenData service currently offers access to over 20 million HCPs and their HCO affiliations, coverings all specialties and classes of trade, spanning across 39 nations.

On May 08, 2017, Veeva Systems announced that Bristol-Myers Squibb, a global pharmaceutical firm, expanded its adoption of Veeva Commercial Cloud in key markets outside the United States. Veeva additionally confirmed that Bristol-Myers Squibb will add Veeva CRM Events Management to better manage field events by streamlining approvals and reducing the complexity of the process.

Last Close Stock Review

On Thursday, June 29, 2017, the stock closed the trading session at $61.36, falling 1.68% from its previous closing price of $62.41. A total volume of 1.26 million shares have exchanged hands. Veeva Systems’ stock price skyrocketed 20.67% in the last three months, 48.57% in the past six months, and 80.36% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have soared 50.76%. The stock is trading at a PE ratio of 93.11. At Thursday’s closing price, the stock’s net capitalization stands at $8.45 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467203

Research Initiated on Financials Stocks: Dundee, Fiera, Capital North American Financial 15 Split, and Global Healthcare Income and Growth Fund

LONDON, UK / ACCESSWIRE / June 30, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Asset Management industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Dundee, Fiera Capital, North American Financial 15 Split, and Global Healthcare Income & Growth Fund. Register for these free reports at: http://protraderdaily.com/register/.

On Thursday, June 29, 2017, the Toronto Exchange Composite Index was down 0.93%, finishing the day at 15,213.42.

Additionally, the Financials index was slightly down by 0.32%, ending the session at 285.11.

Pro-Trader Daily’s complimentary research reports on the following stocks are now available: Dundee Corporation (TSX: DC-A), Fiera Capital Corporation (TSX: FSZ), North American Financial 15 Split Corporation (TSX: FFN), and Global Healthcare Income & Growth Fund (TSX: HIG-UN). Sign up now for your free membership and research reports at: http://protraderdaily.com/register/.

Dundee Corp. (TSX: DC-A)

Toronto, Canada headquartered Dundee Corp.’s stock advanced 2.46%, to finish Thursday’s session at $2.92 with a total volume of 39,350 shares traded. Shares of the Company, which provides wealth management, real estate, resources, and investment services in Canada and the US, are trading below its 50-day and 200-day moving averages. Dundee’s 200-day moving average of $4.33 is above its 50-day moving average of $3.20. See our research report on DC-A.TO at: http://protraderdaily.com/optin/?symbol=DC.A.

Fiera Capital Corp. (TSX: FSZ)

On Thursday, shares in Montréal, Canada-based Fiera Capital Corp. recorded a trading volume of 43,399 shares. The stock ended the day 0.58% higher at $13.84. Fiera Capital’s stock has gained 6.65% in the last three months and 14.21% in the previous one year. The Company’s shares are trading above its 200-day moving average. The stock’s 50-day moving average of $13.86 is above its 200-day moving average of $13.54. Shares of the Company, which provides its services to institutional investors, mutual funds, charitable organizations, and private clients, are trading at a PE ratio of 62.06. The complimentary research report on FSZ.TO at: http://protraderdaily.com/optin/?symbol=FSZ.

North American Financial 15 Split Corp. (TSX: FFN)

On Thursday, shares in North American Financial 15 Split Corp. ended the session 0.23% lower at $8.81 with a total volume of 27,200 shares traded. North American Financial 15 Split’s shares have surged 2.41% in the last one month and 87.03% in the previous one year. The stock is trading above its 50-day moving average. Furthermore, the stock’s 200-day moving average of $9.03 is greater than its 50-day moving average of $8.72. Shares of North American Financial, which invests in an actively managed portfolio of common shares comprised primarily of 15 core large capitalization Canadian and US financial services companies, are trading at a PE ratio of 5.48. Register for free and access the latest research report on FFN.TO at: http://protraderdaily.com/optin/?symbol=FFN.

Global Healthcare Income & Growth Fund (TSX: HIG-UN)

Global Healthcare Income & Growth Fund’s stock closed the day 2.35% lower at $9.15. The stock recorded a trading volume of 28,900 shares, which was above its three months average volume of 6,069 shares. Global Healthcare Income & Growth Fund’s shares have advanced 2.22% in the last one month and 5.60% in the past three months. Furthermore, the stock has gained 13.29% in the previous one year. Shares of the Company, which invests in an equal weight portfolio of equity securities of large-capitalization healthcare companies, are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $9.11 is greater than its 200-day moving average of $8.83. Get free access to your research report on HIG-UN.TO at: http://protraderdaily.com/optin/?symbol=HIG.UN.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 467207

Carbon Monoxide Market 2017-2022 with Key Companies Profile, Supply, Demand, Cost Structure

Carbon Monoxide Market Report added by DeepResearchReports.com to its vast repository provides important statistics and analytical data to give a complete understanding of the industry.

Pune, India – June 30, 2017 /MarketersMedia/

This market research report offers a complete breakdown of the global Carbon Monoxide market through exhaustive information on industry-authenticated market data, facts, statistics, and insights. An apt set of approaches and suppositions in the report back the market forecasts. The report scrutinizes the market by an exhaustive analysis on market dynamics, market size, current trends, issues, challenges, competition analysis, and companies involved.

Carbon Monoxide Industry Key Manufacturers are Linde, Air Liquide, Praxair, Air Products, Messer and Yingde Gases.

Complete report on Carbon Monoxide Industry providing 06 company profiles, their product information and 135 tables and figures is available at http://www.deepresearchreports.com/492878.html

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Carbon Monoxide industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

This report is a collation of actual data, and qualitative and quantitative valuation by industry experts, contributions from industry specialists, and other industry partakers. The report maps the qualitative influence of several market dynamics on market segments and geographies.

In a word, the report provides major statistics on the state of the Carbon Monoxide industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Order a copy of Global Carbon Monoxide Market Report 2017 at http://www.deepresearchreports.com/contacts/purchase.php?name=492878

List of Tables and Figures
Table Global Carbon Monoxide Production by Regions (2011-2016) (K MT)
Table Global Carbon Monoxide Production and Market Share by Regions (2011-2016)
Figure 2011 Global Carbon Monoxide Production Market Share by Regions
Figure 2015 Global Carbon Monoxide Production Market Share by Regions
Table Global Carbon Monoxide Revenue by Regions (2011-2016) (Million USD)
Table Global Carbon Monoxide Revenue Market Share by Regions (2011-2016)
Figure 2015 Global Carbon Monoxide Revenue Market Share by Regions
Table Global Carbon Monoxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Carbon Monoxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Carbon Monoxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Carbon Monoxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Carbon Monoxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Contact Info:
Name: Ritesh Tiwari
Organization: Deep Research Reports
Phone: 1 888 391 5441

Source URL: http://marketersmedia.com/carbon-monoxide-market-2017-2022-with-key-companies-profile-supply-demand-cost-structure/212816

For more information, please visit http://www.deepresearchreports.com

Source: MarketersMedia

Release ID: 212816

Automotive Sensor Market 2017: Industry Application Analysis, Regional Outlook and Analytical Insights to 2021

Automotive Sensors Market Information By Type (Temperature, Pressure, Motion, Position, Optical, Gas, level, Torque, and Mass Air Flow), by Vehicle Type (Low End, Medium End, High End, Heavy Vehicle, and Electrical), By Technology (MEMS, NEMS)

Pune, India – June 30, 2017 /MarketersMedia/

Automotive Sensors market
The Medium end vehicles segment, held the largest share within the global Automotive Sensors Market in 2016. It is expected to retain its dominance in the market growing at a fast pace during the forecast period. However, electric automobiles are estimated to achieve the highest growth as compared to other vehicle types in the next five years. Rising environmental concerns and increasing acceptance of electric vehicles are the major factors contributing towards the growing popularity of electric vehicles.

Automotive Sensor market is expected to grow with the CAGR of about 8-9% from 2016 to 2021. It is projected to be valued at more than $11 billion by 2021. For the Global Automotive Sensor Market drivers are increasing safety demands & growing environmental concern from both government agencies as well as consumers. Rapid technological advancements are also expected to have a profound impact on the market growth.

Automotive Sensor Market Players:
• Analog Devices Inc.
• Avago Technologies
• Bosch Sensortech GmBH
• Bourns Inc.
• Delphi Automotive LLP
• Denso Corporation
• GE Measurement & Control Solutions
• Infineon Technologies
• Micronas Semiconductor Inc.
• Panasonic Corporation
• Sensata Technologies
• TRW Automotive Inc.
• Vishay Intertechnology

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/959

Segments:
The market has been majorly segmented on the basis of type which includes; temperature, pressure, motion, position, optical, gas, level, torque, and mass air flow sensors. The market has been categorized in terms of technology into Micro-Electro-Mechanical Systems (MEMS), Nano-Electro-Mechanical Systems (NEMS), and others. The market has also been segmented on the basis of vehicle types into low end, medium end, high end, heavy vehicle, and electrical vehicles.

Key Findings
– Driving trends such as miniaturization and rising disposable income of middle class population are expected to provide a huge boost to the automotive sector thereby, driving the demand for automotive sensors market
– Factors such as unfledged aftermarket services, and constantly intensifying price competitiveness is hampering the market growth
– Asia-Pacific market is expected to experience the fast growth as compared to other regions within the automotive sensors market

Optical Sensors are the Most Widely Used
Optical sensors are the most extensively used senor type across different type of passenger cars (conventional fuel and electric cars), and held the largest share within the automotive sensors market in 2016. It is expected to continue its dominance during the forecast period, growing with a high growth rate. Motions sensors are estimated to be the second fastest growing segment within automotive sensors market. Increasing demand from its key applications in chassis, power train, and body system on account of rising safety and security requirements is expected to drive the market for automotive motion sensors. The primary application of the automotive sensors is in the power train as a result of which it is the fastest growing segment in the Automotive Sensor Market. The power train segment also accounts for the biggest share in the market. The power train sensors have various advantages including lowering emission and improving fuel economy.

Browse Report @ https://www.marketresearchfuture.com/reports/automotive-sensors-market-959

The report for Global Automotive Sensors Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/automotive-sensor-market-2017-industry-application-analysis-regional-outlook-and-analytical-insights-to-2021/212613

For more information, please visit https://www.marketresearchfuture.com/reports/automotive-sensors-market-959

Source: MarketersMedia

Release ID: 212613